The impact of antiretroviral treatment programs on tuberculosis notification rates

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 12, 2011, Pages 1714-

  Middelkoop, Keren ^a,b   Wood, Robin ^a,b   Bekker, Linda Gail ^a,b  

^a Institute of Infectious Disease and Molecular Medicine   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

COMMUNITY PROGRAM; CONFOUNDING VARIABLE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LETTER; MALAWI; POPULATION RESEARCH; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; SCALE UP; SOUTH AFRICA; TREATMENT OUTCOME; TREND STUDY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; TUBERCULOSIS;

EID: 81455128862     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0545     Document Type: Letter

References (3)

1. Zachariah R, Bemelmans M, Akesson A, et al. Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi. Int J Tuberc Lung Dis 2011; 15: 933-937.
2. Middelkoop K, Bekker L-G, Myer L, et al. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 2011; 56: 263-269.
3. Johnson L F, Kranzer K, Middelkoop K, Wood R. A model of the impact of HIV/AIDS and antiretroviral treatment in the M asiphumelele community. Centre for Infectious Disease Epidemiology and Research working paper; June 2011. http://www.cider.uct.ac.za/publications/publications-rep.php Accessed July 2011.